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Abstract Our objective was to evaluate the ability
of CMR to visualize myocardial injuries over the
course of myocarditis. We studied 42 patients (39
males, 3 females; age 37 ± 14 years) with myocar-
ditis during the acute phase and after 12 ± 9 months.
CMR included function analyses, T2-weighted imag-
ing (T2 ratio), T1-weighted imaging before and after
i.v. gadolinium injection (global relative enhance-
ment; gRE), and late gadolinium enhancement
(LGE). In the acute phase, the T2 ratio was elevated
in 57%, gRE in 31%, and LGE was present in 64% of
the patients. In 32 patients (76%) were any two (or
more) out of three sequences abnormal. At follow-up,
there was an increase in ejection fraction (57.4 ±
11.9% vs. 61.4 ± 7.6; P\0.05) while both T2 ratio
(2.04 ± 0.32 vs. 1.70 ± 0.28; P\0.001) and gRE
(4.07 ± 1.63 vs. 3.11 ± 1.22; P\0.05) signiﬁcantly
decreased. The LGE persisted in 10 patients. Dilated
cardiomyopathy was present in 3 patients and 4
patients received a deﬁbrillator or a pacemaker. A
comprehensive CMR approach is a useful tool to
visualize myocardial tissue injuries over the course of
myocarditis. CMR may help to differentiate acute
from healed myocarditis, and add information for the
differential diagnoses.
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Introduction
The myocardium can be affected by a wide spectrum
of tissue injuries [1]. Non-invasive differentiation of
these injuries might be clinically important. Myocar-
ditis has been reported in up to 12% of young adults
presenting with sudden death [2], and is an important
underlying aetiology of other myocardial diseases
such as dilated [3] and arrhytmogenic right ventric-
ular [4] cardiomyopathy.
In patients with a clinical history, symptoms, and
physical ﬁndings that suggest acute myocardial
disease, a combination of electrocardiogram (ECG)
and seromarkers such as troponin is used to deter-
mine acuity, extent, and location of the myocardial
injury. However, current diagnostic approaches have
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dial ischemia is often low, which may result in
inappropriate treatment [5]. The diagnostic accuracy
of these diagnostic tools is even lower when applied
to patients with myocarditis [6]. Endomyocardial
biopsy (EMB), though the gold standard for tissue
pathology, does not have a clinical role in acute
myocardial diseases, and clinical indications in acute
myocarditis are limited to patients with otherwise
unexplained heart failure [7]. Also, it is well known
that myocardial injuries such as oedema or capillary
leakage are difﬁcult to assess histopathologically.
It is therefore important to establish the pattern and
reversibility of injuries in myocarditis noninvasively.
Due to its tissue characterization capability, cardiac
magnetic resonance (CMR) has provided new
insights into myocarditis-related injuries [8]. Tissue
necrosis can be demonstrated with high spatial
resolution, allowing differentiation of myocarditis
from coronary syndromes [9]. A multisequential
approach has been shown to be promising for the
detection of myocarditis [10], and recently a consen-
sus document on the CMR diagnosis of myocarditis
has been published [11]. This multisequential
approach is based on a combination of techniques;
water sensitive T2 weighted imaging for the detection
of myocardial tissue oedema, and early and late T1
weighted imaging after the injection of contrast
agents such as gadolinium-diethylenetriaminepentaa-
cetic acid (capillary leakage phase and presence of
irreversibly injured myocardium). If two or more of
the three tissue-based criteria are positive, myocardial
inﬂammation can be predicted or ruled out with a
diagnostic accuracy of 78% [11].
Myocarditis may become chronic due to viral
persistence or autoimmune evolution. In this setting
CMR may represent a useful non-invasive tool, and
even guide the execution of EMB when indicated. In
fact, the diagnosis of chronic myocarditis may have
prognostic and therapeutic implications [12]. How-
ever, CMR data on chronic myocarditis are sparse
and conﬂicting. Some investigators have shown that
myocardial oedema as assessed by T2-weighted
imaging is a reversible acute-phase injury [12], while
others have shown oedema in a substantial fraction of
patients with chronic myocarditis [10].
By adapting a comprehensive CMR approach
we have previously shown the ability of early CMR
to detect different tissue injuries in patients with
suspected ST-elevation myocardial infarction
(STEMI) and normal coronary arteries [13]. In the
current report we adapt this CMR approach on
suspected myocarditis patients and provide both the
acute and follow-up data, and moreover, present the
ability of CMR to visualize myocardial injuries over
the course of the disease. A particular interest is
shown in patients with ST-elevation vs. patients with
no ST-elevation on admission.
Materials and methods
We studied two groups of patients who all presented
withacutecardiacsymptoms.Onegroupof26patients
presented with clinical suspicion of acute myocarditis
and was includedretrospectively.The second group of
16patientsmimickingmyocardialinfarction(MI)with
acute ST-elevation was included prospectively
(described in a previous publication [13]). All patients
were admitted for the past 36 months and all were
studiedtwice,withintheﬁrstweekand12 ± 9 months
later (ﬁnalized in March 2010). For inclusion, the
patients had to fulﬁl each of the following clinical
criteria: 1. New onset of or persisting symptoms (chest
painand/ordyspnoe);2.Evidenceofrecentorongoing
myocardial injury through elevation of troponin T; 3.
Exclusion of coronary artery disease by coronary
angiography, except for patients\30 years of age
with a low pre-test probability for coronary artery
disease [11]. Exclusion criteria were also previous MI
(n = 3), takotsubo cardiomyopathy (transient left
ventricular ballooning and no late gadolinium
enhancement (LGE); n = 5), and known contraindi-
cations to CMR (claustrophobia; n = 3).
Based on these inclusion and exclusion criteria
were 26 out of 58 patients presenting with suspicion
of acute myocarditis eligible to participate in the
study. Thirty-two patients showed no troponin T
elevation and were excluded. Among these were 22
patients with a negative CMR and all were dis-
charged with no ﬁnal diagnosis. Ten patients showed
ﬁndings on CMR (discharge diagnosis); focal suben-
docardial LGE (previous MI; n = 3), reduced ejec-
tion fraction (EF) and increased end-diastolic volume
(EDV) (dilated cardiomyopathy (DCM); n = 2),
focal pericardial gadolinium enhancement and effu-
sion (pericarditis; n = 2), increased myocardial
thickness and mass (hypertrophic cardiomyopathy
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123(HCM); n = 1), patchy midwall LGE (cardiac sar-
coidosis; n = 1), and diffuse subendocardial LGE
(cardiac amyloidosis; n = 1).
In the group mimicking MI were 16 out of 49
patients eligible to participate in the study based on
these inclusion and exclusion criteria (excluded
patients are previously described [13]). All partici-
pants gave informed written consent including retro-
spective analysis of data, and the study was approved
by the Regional Ethics Committee and Review Board
of our institution.
Coronary angiography was performed in 31
patients to exclude the presence of coronary artery
disease (\30% diameter stenosis). Creatine kinase
(CK) and creatine kinase-myocardial band (CK-MB)
was measured variably in both groups. C-reactive
protein (CRP) and troponin T were measured on
admission in all patients. ST-segment elevation was
deﬁned as J-point elevation[1 mm in leads II, III,
aVF, I, aVL, and/or[2 mm in leads V1-6, with a
total of minimum 2 mm in the inferior leads, and/or
4 mm in the anterior leads. All patients were asked
for a follow-up CMR, preferably within 6 months.
CMR imaging protocol
The CMR studies were performed on a 1.5-Tesla unit
(Intera CV, Philips Medical Systems, Best, The
Netherlands). A standard ﬁve-channel phased-array
cardiac coil was used with a signal correction
shimming technique. For functional analysis ECG-
gated steady state free precession (SSFP) cine images
of true anatomical axes of the heart were acquired
(TE 1.9 ms, TR 3.8 ms, ﬂip angle 60). Then a breath
hold, black-blood, T2 weighted triple inversion-
recovery (IR) sequence (repetition time (TR) 2 9 R
to R interval, echo time (TE) 80 ms, inversion time
(TI) 180 ms) in short-axis covering the left ventricle
(LV) (slice thickness 10 mm, ﬂip angle 180, pixel
size 0.96 9 0.96 mm) was used. Thereafter a short
axis T1 weighted gradient echo IR sequence (TR
1 9 R to R interval, TE 20 ms, slice thickness
10 mm) both before and after (without any change of
parameters in between) an i.v. bolus of 0.15 mmol/kg
gadolinium-diethylenetriaminepentaacetate (Gd-
DTPA, Magnevist, Bayer Schering Pharma, Berlin,
Germany) using an automated injector (Medrad,
Indianola, USA) was introduced. The post-contrast
measurements started immediately after injection and
lasted for 3–4 min, thus, the images reﬂect gadolin-
ium enhancement at a mean of 2 min (gRE). Finally,
a breath-hold IR sequence (TR 6.1 ms, TE 3.0 ms,
slice thickness 10 mm) was applied after a delay of
15 min (LGE) in short- and long-axis covering the
LV. TI were adjusted to null normal myocardium
using the Look-Locker sequence.
CMR analysis
Off-line analyses were performed on a dedicated
workstation (ViewForum release 5.2, Philips Medical
Systems, Best, The Netherlands). Ventricular vol-
umes and function were measured for both ventricles
using standard techniques. The endocardial and
epicardial borders were drawn manually on each
dynamic image. The LVEF, EDV, systolic wall
thickening (SWT), and myocardial mass were calcu-
lated from the short axis views. Two experienced
observers analyzed all CMR images.
Visualizationofmyocardialoedemawasperformed
using the T2-weighted sequence by measuring the
ratio of global myocardial signal intensity (SI) to
skeletalmuscle(drawninthesameslice).TheT2-ratio
was calculated as SI myocardium/SI skeletal muscle,
and a T2 ratio of 2.0 was used as cut-off value. The
gRE sequence was measured in a similar way, and
regions of interest were manually drawn and copied
from the pre-contrast to the post-contrast images. The
gRE was calculated as previously described [14] and a
cut-off value of 4.0 was used. The LGE sequence was
analyzed segment by segment (17-segment model as
proposed by the American Heart Association) for the
presence, number, and transmurality of LGE areas.
Thespatial extentofenhancementwascalculated([2
standard deviations (SD) compared to a normal
segment)andexpressedingrams(LVmass;calculated
from the product of enhanced volume and speciﬁc
gravityofmyocardium[1.05 g/ml]).TheCMRimages
were also analysed for the presence of concomitant
pericardial effusion and/or enhancement of the peri-
cardial layers. The diagnosis of myocarditis was made
when two or more out of three sequences (T2, gRE,
LGE)wereabnormal.Acontrolgroup,whichhasbeen
presented earlier [13], was used for the validation of
CMRsequencesanddeterminationofimagingspeciﬁc
cut-off values. We also used the validation process to
optimize homogeneity with use of the phased array
coil and signal intensity correction software.
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Each categorical variable is expressed as number and
percentageofpatients.Demographicalandclinicaldata
are presented asmean with SD or proportions. Baseline
characteristics were compared using an independent
sample t-test or Mann–Whitney test as appropriate. A
chi-square test for contingency tables was obtained to
detect associations between categorical independent
variables.Whencomparingcontinuousvariables,atwo-
sided Student’s t test was used. Data were correlated
using Spearman correlation coefﬁcient and linear
regression. P-values less than 0.05 were considered
statistically signiﬁcant, and P-values less than 0.001
highlysigniﬁcant.Allstatisticalanalysiswasperformed
using GraphPad Prism for Macintosh, version 5.0
(GraphPad Software, La Jolla, CA, USA).
Results
Table 1 summarizes the characteristics of the study
population. In total, 42 patients (39 males, three
females; age 37 ± 14 years) were recruited. The
main cardiac symptom was chest pain (80%). Eleven
patients (22 ± 5 years) did not undergo coronary
angiography.
Twelve patients showed coronary stenosis\30%
in at least one coronary artery segment, while 19
patients showed completely normal coronary arteries
with no lumen irregularities. However, provocative
tests for the exclusion of coronary spasm were not
performed. ECG on admission showed nonspeciﬁc
ST-T-changes in 19 patients, ST-elevation in 18
patients (anterior leads 6.5 ± 3.6 mm, inferior leads
1.9 ± 2.2 mm), a normal ECG in four patients, and a
right bundle branch block in one patient. In addition
two of these patients presented with AV-block and
two patients with incomplete intraventricular block.
The average time between the initial symptoms and
admission was 0.8 ± 1.2 days, and between admis-
sion and the ﬁrst CMR 2.9 ± 2.4 days. There was a
mild to moderate elevation in troponin T
(0.93 ± 0.90 lg/l) for all patients, although two
patients showed a borderline value of 0.02 lg/l.
CRP (56 ± 78 mg/l) showed increased values in 23
patients (55%), and 26 patients (62%) reported a
recent history of infection or ﬂu-like symptoms
before the onset of cardiac symptoms. Also, 2
patients with diabetes had an ongoing ketoacidosis
on admission. There was a moderate increase in CK
(48 ± 63 lg/l) and CK-MB (517 ± 364 lg/l).
Acute phase CMR
Three T1 weighted sequences early after i.v. Gd-
DTPA (gRE) were of suboptimal quality, otherwise
all CMR examinations were of diagnostic quality and
results are summarized in Table 2. The T2 ratio was
elevated in 24 patients (57%), gRE in 13 patients
(31%), and LGE was present in 27 patients (64%). In
32 patients (76%) were any two (or more) out of three
sequences (T2, gRE, LGE) abnormal (Fig. 1). Com-
pared to controls, the T2 ratio was signiﬁcantly
elevated (2.04 ± 0.32 vs. 1.68 ± 0.19, P\0.001),
as was the gRE (4.07 ± 1.63 vs. 2.95 ± 0.82; P\
0.05), and the myocardial mass (150 ± 28 vs.
126 ± 36 g; P\0.05). There was no signiﬁcant
change of EF (57.4 ± 11.9 vs. 62.8 ± 7.3%; ns),
EDV (158 ± 46 vs. 160 ± 42 ml; ns), or SWT (61 ±
18 vs. 75 ± 20%; ns) compared to controls. LGE
mass was 9.2 ± 8.6 g and LGE were mainly seen in
the infero-lateral segments (4, 5, 10, 11; 86%), and all
LGE was seen in the mid or subepicardial regions.
Pericardial effusion was seen in seven patients (17%)
at the acute event.
Prognosis and follow-up CMR
Each of the 42 patients survived the acute event.
Clinical follow-up was completed for all patients and
revealed no major adverse cardiac events. 36 patients
(86%)returnedforthefollow-upCMR12 ± 9 months
Table 1 Baseline characteristics
n = 42
Mean age (years) 37 ± 14
Male sex [n (%)] 39 (93)
Diabetes [n (%)] 5 (12)
Hypertension [n (%)] 6 (14)
Smoking [n (%)] 13 (31)
Infection or ﬂu [n (%)] 26 (62)
Mean troponin T (lg/l) 0.93 ± 0.95
Mean CK (lg/l) 48 ± 63
Mean CK-MB (lg/l) 517 ± 364
Mean CRP (mg/l) 56 ± 78
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123after presentation. Three patients declined the follow-
up CMR and three patients were unable to perform the
CMR due to an implanted cardioverter-deﬁbrillator
(ICD; n = 2) or a pacemaker (PM; n = 1). Another
patient had the follow-up CMR performed before the
PM implantation. There was a signiﬁcant decrease in
myocardial oedema (T2 ratio; 2.04 ± 0.32 vs.
1.70 ± 0.28; P\0.001), gRE (4.07 ± 1.63 vs.
3.11 ± 1.22; P\0.05) (Figs. 1 and 2), and myocar-
dial mass (150 ± 28 g vs. 137 ± 24; P\0.05), as
well as an increase of LVEF (57.4 ± 11.9% vs.
61.4 ± 7.6; P\0.05) (Fig. 2) and systolic wall
thickening (SWT; 61 ± 18% vs. 72 ± 26%; P\
0.05). No signiﬁcant change was seen in EDV (158 ±
46vs.143 ± 34;ns)orLGEmass(9.2 ± 8.6vs.5.5 ±
2.2 g; ns) compared to the acute phase. The LGE
persisted in 10 patients and pericardial effusion in 4
patients. Totally 8 patients had two or more abnormal
sequences (T2, gRE, LGE) also at follow-up. There
was no relation between the degree of change in CMR
parameters of myocardial injury (delta-T2, delta-gRE,
and presence of LGE) and the change in functional
parameters over the course of myocarditis. Also, the
extent of LGE did not correlate with any of the
functional parameters. One patient was readmitted
with acute myocarditis within the observation period.
ST-elevation vs. non-ST-elevation
There was a signiﬁcant difference in time to admis-
sion and CMR between the groups. Time from the
initial symptoms to admission was signiﬁcant lower
Table 2 CMR results at
baseline and follow-up
ns non signiﬁcant
Baseline (n = 42) Follow-up (n = 36) P value
LV EF (%) 57.4 ± 11.9 61.4 ± 7.6 \0.05
LV EDV (ml) 158 ± 46 143 ± 34 ns
LV mass (g) 150 ± 28 134 ± 24 \0.05
LV SWT (%) 61 ± 18 72 ± 26 \0.05
Elevated T2 ratio [n (%)] 24 (57) 4 (11) \0.001
Mean T2 ratio 2.04 ± 0.32 1.70 ± 0.28 \0.001
Elevated gRE [n (%)] 13 (31) 6 (17) \0.05
Mean gRE 4.07 ± 1.63 3.11 ± 1.22 \0.05
LGE [n (%)] 27 (64) 10 (28) \0.001
Any 2 out of 3 sequences
Abnormal (%) 32 (76) 8 (22) \0.001
Mean LGE mass (g) 9.2 ± 8.6 5.5 ± 2.2 ns
Pericardial effusion [n (%)] 7 (17) 4 (11) ns
Fig. 1 Patient with myocarditis (a–l). CMR demonstrates T2-
weighted (a, b, g, h), gRE (c, d, i, j), and LGE (e, f, k, l) during
the acute phase (top) and follow-up (bottom). During the acute
phase, lateral intramural signal elevation is seen in all images
(white arrows). At follow-up, the T2 changes are not seen, but
gRE and LGE lesions persisted (spotty appearance; white
arrows/circles)
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non-ST-elevation group (4 ± 2 vs. 29 ± 36 h;
P = 0.002), as was the time from admission to
CMR (0.9 ± 0.6 vs. 4.1 ± 2.2 days; P\0.001). For
the ST-elevation group on admission there was a
trend toward decreased LVEF (55.9 ± 7.3 vs.
59.9 ± 10.8%; P = 0.13) and gRE (3.82 ± 1.77 vs.
4.27 ± 1.63; P = 0.24), as well as increased T2 ratio
(2.09 ± 0.10 ± 2.01 ± 0.41; P = 0.15) compared to
the non-ST-elevation group. At follow-up there was a
similar trend toward decreased LVEF (58.7 ± 8.1 vs.
63.3 ± 6.6; P = 0.07) and gRE (2.65 ± 0.95 vs.
3.43 ± 1.31; P = 0.09) for the ST-elevation group.
The differences did not reach statistical signiﬁcance,
probably in part due to a relatively small sample size.
However, the LGE mass was signiﬁcantly increased
for the ST-elevation group both on admission
(12.3 ± 11.9 vs. 7.1 ± 4.6 g; P\0.05) and at
follow-up (6.8 ± 2.7 vs. 4.5 ± 1.3 g; P\0.05)
compared to the non-ST-elevation group.
Differential diagnosis
DCM was present in three patients (Fig. 3). One
patient had a heart arrest shortly after admission
(EDV 254 ml, EF 52%, no LGE), and one patient
presented with a severely reduced EF of 15% (EDV
202 ml, no LGE). The third patient had a moderately
reduced EF of 31% (EDV 348 ml, gRE 8.1 and LGE
in lateral segments 5,6,11,15,16). Two of the DCM
patients had an ICD successfully implanted. Two
other patients had an AV-block on admission and one
was successfully treated for a heart arrest (no LGE).
The second patient had an AV-block grade 2 that
subsequently became grade 3 (gRE 4.66 and LGE in
segments 2 and 3). Both these patients successfully
had a PM implanted. Additionally, four patients
presented with a minimally raised troponin T (0.18 ±
0.14 lg/l) as the only ﬁnding, since all CMR
parameters were normal and no LGE was demon-
strated in the acute phase or at follow-up.
Discussion
CMR has emerged as a valuable tool in the non-
invasive diagnosis of myocarditis since the ﬁrst case
series with T2-weigthed spin-echo sequences in 1991
[15] and gadolinium-enhanced T1-weighted images to
serially image the natural history of acute myocarditis
in 1998 [14]. A combination of techniques with the
introduction of T2-weighted sequences and compar-
ison of myocardial with skeletal muscle enhancement,
have further improved the diagnostic accuracy [16]. A
consensus report from 2009 suggested criteria pro-
viding evidence for or against myocardial inﬂamma-
tion based on CMR ﬁndings [11].
This suggested multisequential approach for sus-
pected myocarditis has been performed in our
institution since 2007. So far reports documenting
Fig. 2 Line graphs demonstrate the changes in ejection fraction (EF), gRE, and T2 ratios over the course of myocarditis. The
increased EF (P\0.05) is paralleled by a normalization of gRE (P\0.05) and T2 ratio (P\0.001)
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We have in this report been able to show that this
CMR approach is capable of monitoring myocardial
injuries over the course of myocarditis. Also, this is
the ﬁrst study to show increased myocardial injuries
for myocarditis patients with ST-elevation compared
to non-ST-elevation. In addition, our study showed
that a large group of patients (34%) had markedly
elevated troponin in the absence of LGE. Accord-
ingly, CMR added information for the differential
diagnosis, which is important because of different
treatment strategies.
Myocardial tissue oedema [17] and increased
capillary leakage [18] are the most likely pathological
correlates to the T2 ratio and gRE. These injuries are
reversible and transient features of the inﬂammatory
response, and could thus explain our CMR ﬁndings.
Our study showed that both T2 and gRE in a majority
of patients decreased over the course of myocarditis,
and that this reduction was associated with improve-
ment in some LV function parameters. These ﬁndings
are supported by the recently reported observations
by Zagrosek [19]. It is possible that a complete
recovery of myocarditis is associated with a reduction
of the T2 ratio and gRE as in our study. Also, we
have recently shown that T2 changes reﬂecting
myocardial oedema are features of the acute but not
of the chronic injury in patients with suspected
STEMI and normal coronary arteries [13]. A recent
CMR study that also included EMB found that T2
changes are rare in chronic myocarditis [12]. The
same ﬁndings have also been shown in myocardial
infarction [20], lending further support to our current
ﬁndings, and as such, CMR may offer a usable tool to
monitor disease progression or regression.
The incidence of LGE in myocarditis is a contro-
versial issue. LGE persisted over the course of
myocarditis in 28% of our patients, which is a
somewhat lower percentage compared to some reports
[21], but higher compared to others [10]. The
discrepancy may be related to differences in patient
populations or study designs. Furthermore, the pattern
of myocardial injury is inﬂuenced by the virus type
[22]. We recently published a case report of the ﬁrst
H1N1 myocarditis (3 abnormal sequences) and a
complete recovery after 3 months [23]. In fact, our
ﬁndings showed that a majority of the patients had
reversible myocardial injury, and that sensitivity of
LGE will remain a controversial issue due to the fact
that 34% of the patients had markedly elevated
troponin in the absence of any LGE. A possible
explanation is CMRs inability to demonstrate diffuse
myocardial changes as possibly encountered in some
myocarditis patients. This is an important reason to
perform a comprehensive CMR approach in patients
with suspected myocarditis. A meta analysis (from the
consensus report) showed that if all sequences can be
performed and 2 or more of the 3 tissue-based criteria
Fig. 3 CMR demonstrates a patient with DCM (a–h). EF is
19% and EDV 348 ml (a; end-diastole, b; end-systole). The
T2-weighted (c, d) and gRE (e, f) images are normal, but there
is lateral epicardial LGE (g, h; white arrows). This patient had
later an ICD implanted and no follow-up CMR was done
Int J Cardiovasc Imaging (2012) 28:327–335 333
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dicted or ruled out with a diagnostic accuracy of 78%;
if only LGE imaging is performed, the diagnostic
accuracy is reduced to 68% [11]. Also the presence of
pericardial effusion as seen in 7 of our patients may
provide additional evidence for myocarditis.
Other than expected, ﬁndings of LGE was not
always associated with a focal increase in T2 signal
or increased gRE, neither was there any signiﬁcant
correlation between these ﬁndings. It seems that the
evolution pattern of myocardial oedema and capillary
leakage might be different from LGE. Accordingly,
at a particular ‘‘time window’’, only one or two of
three parameters are detectable. Serial studies have
shown that gRE needs a longer time delay after the
onset of symptoms to become positive, and although
there was a difference in time delay between our
patients with or without ST-elevation, the time delay
might not be long enough. The T2 abnormalities
allow the detection of tissue oedema, a substantial
and rapid feature of the acute inﬂammatory reaction
in the myocardium. Possibly, at least in some
patients, focal oedema marks a less severe form of
injury that may not progress to actual necrosis. On the
other hand, the differences in time delay might
explain the signiﬁcant difference that was seen in
LGE mass between the groups, as an increased LGE
mass for the ST-elevation group tended to show
increased T2 ratio and gRE as well as decreased
LVEF on admission.
Our patient population was fairly homogenous
with predominantly young males and nearly normal
LV function and dimensions, and a complete recov-
ery was seen in a majority of our patients. This
ﬁnding is in agreement with previous reports [19].
Mahrholdt recently observed an association between
the pattern of LGE and LV remodelling in myocar-
ditis [21]. However, approximately 50% of patients in
that study presented with LV dilatation and impaired
EF in which initial EDV emerged as an independent
predictor of later LV dilatation. The link between
myocarditis and the later development of DCM is
well established [24]. Yet only a fraction of myocar-
ditis patients progress to dilated DCM. Three of our
patients presented with DCM, but only one showed
LGE and increased gRE. It is not known whether
myocarditis patients with positive CMR parameters
may be more likely to develop DCM, but it seems
intriguing to postulate. Also, whether myocarditis
patients would be more liable to develop ventricular
arrhythmias will be a future research focus.
Limitations
The lack of EMB is a limitation of our study.
However, the sensitivity of EMB is limited [22], and
it may have severe complications. Also, the majority
of our patients were young with an uneventful
recovery, and we avoided unnecessary risks for the
patients. There is a theoretical possibility that some
patients suffered from undetected coronary heart
disease, such as a resolved thrombus, but the lack of
scarring by CMR makes an ischemic injury unlikely.
Both the body coil and the phased array coil have
been used in the T2 and the gRE sequences in other
studies. The use of the body coil and axial views may
show somewhat lower noise levels, but in our
experience optimized use of the phased array coil
with effective signal intensity correction software
allows sufﬁcient signal homogeneity. Finally, the
time to follow-up was variable, reﬂecting the retro-
spective nature of this analysis.
Conclusion
In conclusion, this CMR study provides further
insights into the pathophysiological mechanisms in
myocarditis, and demonstrates that a comprehensive
CMR approach is able to monitor myocardial tissue
injuries over the course of the disease. Both acute and
chronic injuries tend to be more pronounced in
patients with initial ST-elevation. Additionally, CMR
has incremental value for differential diagnoses and
therapeutic decision-making, and therefore recom-
mended in all patients with acute cardiac symptoms,
elevated cardiac biomarkers, and unobstructed coro-
nary arteries.
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